ArticleJournal for immunotherapy of cancer2023

Correction: αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.